A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 33 050 KRW -2.51% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Operating Income Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Operating Income
-â‚©35.8B
CAGR 3-Years
16%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©369.6B
CAGR 3-Years
-22%
CAGR 5-Years
6%
CAGR 10-Years
9%
SK Bioscience Co Ltd
KRX:302440
Operating Income
-â‚©12B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Income
â‚©137.7B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©102.2B
CAGR 3-Years
31%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Income
-â‚©8.1B
CAGR 3-Years
20%
CAGR 5-Years
4%
CAGR 10-Years
N/A

See Also

What is ABL Bio Inc's Operating Income?
Operating Income
-35.8B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Operating Income amounts to -35.8B KRW.

What is ABL Bio Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-21%

Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for ABL Bio Inc have been 16% over the past three years , -21% over the past five years .

Back to Top